Strontium ranelate: short- and long-term benefits for post-menopausal women with osteoporosis.

Rheumatology (Oxford) · 2008 · PMC2427169 · PMID 18556647

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

did not reach statistical significanceP = 0.11not close (p > 0.1)

Over 3 yrs, hip fractures occurred in 7.4% of the women receiving placebo and in 5.2% of women receiving strontium ranelate, and this difference did not reach statistical significance ( P = 0.11).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.